[1]
H. Ikeda, “Can the Abbott RealTime hepatitis C virus assay be used to predict therapeutic outcomes in hepatitis C virus-infected patients undergoing triple therapy?”, Turkish Journal of Gastroenterology, vol. 27, no. 2, pp. 165–172, Jan. 2016.